Otolith Labs Announces Data Demonstrating Otolith Technology Effectiveness on Cybersickness from Virtual Reality in Exploratory Study
Original research article published by Frontiers, a top peer-reviewed scientific journal
WASHINGTON, Feb. 13, 2025 /PRNewswire/ — Otolith Labs, a medical technology company developing prescription medical devices for the treatment of vestibular disorders, announced results from an exploratory user study investigating the effect of vestibular stimulation on cybersickness from virtual reality (VR) experiences. The study demonstrated that subjects utilizing the Otolith technology had improved virtual environment experiences with lower reported nausea and longer VR durations.
